Becton Dickinson's stock tumbles, as lowered earnings guidance offsets profit beat Shares of Becton Dickinson & Co. tumbled 11% in premarket trading, after the medical technology company reported Research Reports Coverage on Healthcare Stocks -- Antares ... Research Reports Coverage on Healthcare Stocks -- Antares Pharma, Insulet, Glaukos, and CR Bard New Jersey headquartered CR Bard Inc.'s stock ended the day 0.03% higher at Research Reports About C.R. Bard, Inc. | Bard has joined BD Bard's capital stock is listed and traded on the New York Stock Exchange under the symbol "BCR". 1968. Bard builds a 172,000 square foot manufacturing plant at the Murray Hill, New Jersey location. Research Reports Initiation on Medical Supplies Stocks ...
Get breaking news and analysis on C. R. Bard, Inc. (BCR) stock, price quote and chart, trading and investing tools. Sign in Marketplace Subscribe. CR Bard's Buyback Report Card.
28 Dec 2017 C.R. Bard (BCR). C.R. Bard (BCR). 331.24 -1.95 (- Real time C.R. Bard (BCR) stock price quote, stock graph, news & analysis. 24 Apr 2017 C.R. Bard (NYSE: BCR) stock soared 19.5% higher on Monday after medical supply giant Becton, Dickinson (NYSE:BDX) announced it's C. R. Bard is a developer, manufacturer, and marketer of medical technologies. C. R. Bard is registered under the ticker NYSE:BCR . Stock Symbol NYSE:BCR 29 Dec 2017 For Bard registered shareholders who hold Bard stock certificates or a In 2017, BD welcomed C. R. Bard and its products into the BD family. C. R. Bard, Inc. is a multinational developer, manufacturer and marketer of medical devices in vascular, urology, oncology and surgical specialty areas. Get to BCR / Bard (C.R.), Inc. - Institutional Ownership and Shareholders File Date, Form, Investor, Avg Share Price, Shares, Shares Changed (%), Value ($1000)
Apr 23, 2017 · CR Bard Inc has agreed to be acquired by fellow medical devices giant Becton Dickinson and Co for $24 billion in cash and stock.The merger entails that BCR shareholders will receive $222.93 in cash and 0.5077 shares of BDX stock per Bard share. The total value of the deal is $317.00 per Bard common share, which is a 25% premium over the stock’s Friday closing price of $253.07.
Looking for a stock symbol, but only know the company name, or a portion of the company name? Use this handy form to search our extensive database of stock symbols. Simply type the company name, or a portion of the company name into the space below, select an exchange (or "all" if you want to search all exchanges), then click the "Search" button. BCR Stock Quote - C. R. Bard, Inc. (New Jersey) Stock ... C. R. Bard, headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products. Why C.R. Bard Shares Skyrocketed 19.5% Today | The Motley Fool C.R. Bard (NYSE: BCR) stock soared 19.5% higher on Monday after medical supply giant Becton, Dickinson announced it's acquiring the company for about $24 billion in cash and stock. So what BCR Historical Stock Prices BCR (BCR) has the following price history information. Looking back at BCR historical stock prices for the last five trading days, on December 22, 2017, BCR opened at $331.25, traded as high as $333.67 and as low as $330.69, and closed at $332.28. Trading volume was a total of 1.43M shares.